E-LIB Suche - Ergebnisse für: Zastrozhin, Michael Sergeevich

1

Pharmacodynamic genetic polymorphisms affect adverse drug r..:

Zastrozhin, Michael Sergeevich ; Brodyansky, Vadim ; Skryabin, Valentin...
Pharmacogenomics and Personalized Medicine. 10 (2017) - p. 209-215 , 2017

Link: https://doi.org/10.2147/..

2

The correlation between CYP2D6 isoenzyme activity and halop..:

Sychev, Dmitry ; Zastrozhin, Michael Sergeevich ; Smirnov, Valery...
Pharmacogenomics and Personalized Medicine. 9 (2016) - p. 89-95 , 2016

Link: https://doi.org/10.2147/..

3

Pharmacodynamic genetic polymorphisms affect adverse drug r..:

Zastrozhin, Michael Sergeevich ; Brodyansky, Vadim ; Skryabin, Valentin...
info:eu-repo/semantics/altIdentifier/doi/10.2147/PGPM.S140700. , 2017

Link: https://www.dovepress.co..

4

Global burden of peripheral artery disease and its risk fac..:

Kim, Min Seo ; Hwang, Jimin ; Yon, Dong Keon...
https://linkinghub.elsevier.com/retrieve/pii/S2214109X23003558. , 2023

Link: https://doi.org/10.1016/..

5

Global burden of chronic respiratory diseases and risk fact..:

Momtazmanesh, Sara ; Moghaddam, Sahar Saeedi ; Ghamari, Seyyed-Hadi...
Journal: eClinicalMedicine. , 2023

Link: http://hdl.handle.net/10..

6

Global burden of peripheral artery disease and its risk fac..:

Kim, Min Seo ; Hwang, Jimin ; Yon, Dong Keon...
The Lancet Global Health, 2023, 11:10, s. E1553-E1565. , 2023

Link: http://urn.kb.se/resolve..

7

Hepatitis B and C in Europe: an update from the Global Burd..:

Cortesi, Paolo Angelo ; Fornari, Carla ; Conti, Sara...
info:eu-repo/semantics/altIdentifier/pmid/37633679. , 2023

Link: https://hdl.handle.net/2..

8

Use of multidimensional item response theory methods for de..:

Nichols, Emma ; Abd-Allah, Foad ; Abdoli, Amir...
https://acuresearchbank.acu.edu.au/item/8y722/use-of-multidimensional-item-response-theory-methods-for-dementia-prevalence-prediction-an-example-using-the-health-and-retirement-survey-and-the-aging-demographics-and-memory-study. , 2021

Link: https://acuresearchbank...

9

Hearing loss prevalence and years lived with disability, 19..:

Sathian, Brijesh ; Alahdab, Fares ; Akalu, Yonas...
b168cf2e-45c3-4891-aba2-5c56997c3937. , 2021

Link: http://acikerisim.sdu.ed..

10

Investigating the Use of Pharmacogenetic and Pharmacometabo..:

Skryabin, Valentin Yurievich ; Zastrozhin, Mikhail Sergeevich ; Parkhomenko, Aleksandra Aleksandrovna...
Hospital Pharmacy. 58 (2023) 4 - p. 363-367 , 2023

Link: https://doi.org/10.1177/..

11

Time trends in tuberculosis mortality across the BRICS: an ..:

Zou, Zhiyong ; Liu, Guangqi ; Hay, Simon I....
eClinicalMedicine. 53 (2022) - p. 101646 , 2022

Link: https://doi.org/10.1016/..

12

CYP2D6 gene polymorphic markers role in determining the opt..:

Sychev, Dmitry A. ; Parusov, Andrei I. ; Loranskaya, Irina D....
Terapevticheskii arkhiv. 94 (2022) 2 - p. 200-208 , 2022

Link: https://doi.org/10.26442..

13

Using a personalized clinical decision support system for b..:

Zastrozhin, Michael S. ; Sorokin, Aleksandr S. ; Agibalova, Tatyana V....
Human Psychopharmacology: Clinical and Experimental. 33 (2018) 6 - p. , 2018

Link: https://doi.org/10.1002/..

14

The influence of CYP3A5 polymorphisms on haloperidol treatm..:

Zastrozhin, Mikhail Sergeevich ; Grishina, Elena ; Ryzhikova, Kristina Anatolievna...
Pharmacogenomics and Personalized Medicine. 11 (2017) - p. 1-5 , 2017

Link: https://doi.org/10.2147/..

15

P.145 How do CYP3A4 genetic polymorphisms affect the effica..:

Skriabin, V. ; Sergeevich, M. Zastrozhin ; Alekseevich, E. Bryun.
European Neuropsychopharmacology. 29 (2019) - p. S116 , 2019

Link: https://doi.org/10.1016/..